TWN Info Service on Health Issues (2017)

• Sweden's success in controlling antibiotic resistance
  (19 Dec 17)
• US blocks outcomes, collapsing WTO ministerial conference like house of cards
  by D. Ravi Kanth (15 Dec 17)
• Argentina: Debate on glyphosate use comes to a head
  by IPS/Daniel Gutman (14 Dec 17)
• Action Needed to Avoid the End of Modern Medicine
  by Martin Khor (13 Dec 17)
• Action needed now on antibiotic resistance
  by CAP (13 Dec 17)
• Medicines access study absent from proposed prioritised activities on substandard and falsified medical products
  (30 Nov 17)
• Antimicrobial Stewardship in the Western Pacific and South East Asia Regions
  (30 Nov 17)
• WHO's Study on Substandard and Falsified Medical Products: Questionable Data and Analysis
  (28 Nov 17)
• Proposed WHO criteria on medicines in transit open door for seizures
  by TWN (22 Nov 17)
• New South Centre Paper - The International Debate on Generic Medicines of Biological Origin
  (21 Nov 17)
• New Research Finds Common Herbicides Cause Antibiotic Resistance
  (17 Nov 17)
• Hepatitis C Buyers' Clubs Grow Worldwide As A Way To Obtain Affordable Treatment
  by Tatum Anderson (14 Nov 17)
• MEDIA RELEASE: Pharmaniaga, Pharco and DNDi Sign Agreement to Provide Affordable Hepatitis C Treatment in Malaysia
  (13 Nov 17)
• Appeal to sign petition against golf course project
  (13 Nov 17)
• Sharing national experiences in use of compulsory licenses
  by Kanaga Raja (03 Nov 17)
• Comment on Draft Concept Note towards WHO's 13th General Programme of Work
  (02 Nov 17)
• ReACT Conference Identifies Challenges and Actions to Tackle AMR in Africa
  (26 Oct 17)
• AIDAN Press Statement - Access to health products is non-negotiable
  (25 Oct 17)
• TWN Statements during the 57th Series of Meetings of WIPO Assemblies
  (23 Oct 17)
• WIPO: Diluted mandate for genetic resource/traditional knowledge work; postponed decisions on design law treaty and External Offices
  by TWN (23 Oct 17)
• (The Wire) How the University of California Is Fighting Proxy Patent Battle for Expensive Cancer Drug in India
  by Anoo Bhuyan (19 Oct 17)
• How pharma firms & corporate hospitals fleece patients
  by K. M. Gopakumar (17 Oct 17)
• Super malaria spreads in South East Asia
  by James Gallagher (16 Oct 17)
• WIPO: Draft texts on IGC dilute the mandate
  by K. M. Gopakumar (12 Oct 17)
• World running out of antibiotics, says WHO
  (10 Oct 17)
• Little evidence to support WIPO's formula 'IP = Innovation = Development'
  by K. M. Gopakumar (10 Oct 17)
• Antibiotic misuse in poultry and multidrug-resistant bacteria
  (21 Sept 17)
• Pharma companies inflating R&D costs?
  by TNN (18 Sept 17)
• Australian report on antimicrobial use and resistance
  (11 Sept 17)
• Book Review - One Health and the Politics of Antimicrobial Resistance
  by Jean B. Patel (06 Sept 17)
• New drug to treat drug resistant gonorrhea
  (30 Aug 17)
• Antibiotic-resistant gonorrhea threat
  (28 Aug 17)
• State of discussion on AMR action
  by Mirza Alas (25 Aug 17)
• WHA side event on AMR
  by Mirza Alas (18 Aug 17)
• Action needed now on Hepatitis C
  by Martin Khor (09 Aug 17)
• RCEP trade agreement and access to medicines
  (04 Aug 17)
• Urgent action needed on Hepatitis C
  by Martin Khor (04 Aug 17)
• Book review - An Access Regime based on Indian Patents Act
  by Feroz Al (31 Jul 17)
• The Case For Nations To Act On Medicines Access
  by William New (25 Jul 17)
• Reclaiming Policies for the Public
  (12 Jul 17)
• States called upon to respect, protect and fulfil right to health
  by Kanaga Raja (04 Jul 17)
• WTO TRIPS Council debates IP and the public interest
  by Kanaga Raja (28 Jun 17)
• South nations raise stakes on IP-Public Interest imbalance
  by D. Ravi Kanth (13 Jun 17)
• WHO DG-elect faces herculean task on "Health as Rights issue"
  by D. Ravi Kanth (31 May 17)
• Member States raise concerns over secondment criteria and guidelines
  by Mirza Alas (30 May 17)
• Dr Tedros of Ethiopia elected as new WHO DG
  by Kanaga Raja (29 May 17)
• Secretariat proposes non-state actor secondment to 'sensitive posts'
  by K. M. Gopakumar (26 May 17)
• WHO R&D Blueprint - Where’s the Benefit Sharing?
  by Sangeeta Shashikant (12 May 17)
• Trump's first 100 days - a serious cause for concern
  by IPS/Martin Khor (26 Apr 17)
• After India, I-MAK files legal challenge against Gilead's hepatitis C drug sofosbuvir in China
  by Ramesh Shankar (25 Apr 17)
• Reflections on World Health Day
  by IPS/Martin Khor (20 Apr 17)
• WHO Lists Antibiotic Development Priorities
  by Tracy Vence (19 Apr 17)
• CSOs launch Europe-wide patent challenge on hepatitis C drug
  by Kanaga Raja (06 Apr 17)
• Ugly dance of global hegemon, source of concern and confusion
  by D. Ravi Kanth (14 Mar 17)
• Rights Council holds panel discussion on access to drugs
  by Kanaga Raja (13 Mar 17)
• Mitigating the Regulatory Constraints Imposed by IP Rules under FTAs
  (06 Mar 17)
• Cardiac stents put under price control in India
  by T.K. Rajalakshmi (02 Mar 17)
• Avoid patent clauses in trade treaties that can kill millions
  by IPS/Martin Khor (02 Mar 17)
• India "Shuts Health Mission Gate on Bill & Melinda Gates Foundation"
  by Anubhuti Vishnoi (10 Feb 17)
• Brazilian National Institute of Industrial Property Rejects Truvada® Patent Application
  (08 Feb 17)
• Resolution On Compulsory Licences For Patented Medicines Passes In Chile
  by Kim Treanor (08 Feb 17)
• Global day of action against Roche's inhumanity
  (07 Feb 17)
• Pandemic flu Framework a “success story” with challenges
  by Sangeeta Shashikant (07 Feb 17)
• United Nations: S-G calls for lifting of Trump's US travel ban
  by Kanaga Raja (07 Feb 17)
• US travel ban breaches Rights obligations, say UN experts
  by Kanaga Raja (07 Feb 17)
• Shocks for Developing Countries from President Trump’s First Days
  by Martin Khor (02 Feb 17)
• World Health Assembly to discuss UN high level report on access to medicines
  by Sangeeta Shashikant (02 Feb 17)
• How charity is fuelling a superbug in India?
  by Ruhi Kandhari (02 Feb 17)
• Countries reaffirmed commitment, considered progress on tackling antimicrobial resistance
  by Mirza Alas (31 Jan 17)
• WHO: Civil society calls for deferment of “official relations” status to Gates Foundation
  by TWN (30 Jan 17)
• TRIPS amendment on access to cheaper drugs comes into force
  by Kanaga Raja (25 Jan 17)
• WHO: Member States raise information deficit for decisions on official relations
  by TWN (19 Jan 17)
• China approves generic version of three vital medicines
  (18 Jan 17)